nach oben

CardioVascular and Interventional Radiology

Erschienen in:

01.06.2014 | Clinical Investigation

Safety and Efficacy of a Circumferential Clip-Based Vascular Closure Device in Cirrhotic and Coagulopathic Patients with Hepatocellular Carcinoma After Doxorubicin Drug-eluting Beads Transarterial Chemoembolization

verfasst von: Hasmukh J. Prajapati, Shoaib Rafi, Faramarz Edalat, David A. Kooby, Hyun S. Kim

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study was designed to investigate the safety and efficacy of the circumferential clip-based (StarClose) vascular closure device (VCD) in coagulopathic and cirrhotic patients with hepatocellular carcinoma (HCC) after doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE).

Methods

Consecutive cirrhotic patients with HCC, who underwent DEB TACE from November 2009 to February 2012, were included in the study. Based on platelet count (PC) and international normalized ratio (INR), these patients were further divided into group A (PC ≥ 150 k/dl), B (PC = 50–149 k/dl), C (PC < 50 k/dl), D (INR ≤ 1.2), E (INR = 1.21–1.5), and F (INR > 1.5). StarClose VCD was attempted in each case. Technical success was defined as complete hemostasis achieved within 3 min after the closure. Periprocedural complications were studied.

Results

A total of 350 DEB TACEs were performed in 195 patients (mean age 61.6 years, SD 9.1). StarClose VCD was attempted in all cases. StarClose device was not deployed in 2.2 % (8/350) of cases due to improper femoral punctures and severe atherosclerotic disease. Technical success rate was 97.1 % (332/342). All groups (A–F) were similar in age, sex, body mass index, and technical success rate (P > 0.05). Minor complications occurred after 1.8 % (6/342) of cases. VCD was repeatedly used in 92 patients with 96.2 % (230/239) of technical success rate. There was no major complication related to VCD. There was no access site infection, leg ischemia, and pseudoaneurysm or symptomatic groin hematoma.

Conclusions

Circumferential clip based (StarClose) arterial closure device achieved effective and rapid hemostasis after DEB TACE with minimal complications in cirrhotic patients with HCC and coagulopathy. StarClose deployment and reaccess in patients with PC < 50 k/dl and INR > 1.2 are safe and effective.

Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol 33(1):41–52CrossRef

Malagari K, Chatzimichael K, Alexopoulou E et al (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 31(2):269–280CrossRef

Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol 101(6):476–480PubMed

Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734–1739PubMedCrossRef

Prajapati H, Spivey J, Hanish S et al (2012) mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE). Ann Oncol 24(4):965–973PubMedCrossRef

Prajapati HJ, Dhanasekaran R, El-Rayes BF et al (2013) Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. J Vasc Interv Radiol 24:307–315PubMedCrossRef

Prajapati HJ, Rafi S, El-Rayes BF, Kauh JS, Kooby DA, Kim HS (2012) Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization. J Vasc Interv Radiol 23(10):1286–1293 e1281PubMedCrossRef

Pluta A, Gutkowski K, Hartleb M (2010) Coagulopathy in liver diseases. Adv Med Sci 55(1):16–21PubMedCrossRef

Hoffer EK, Bloch RD (2003) Percutaneous arterial closure devices. J Vasc Interv Radiol 14(7):865–885PubMedCrossRef

10.

Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinksi EJ, Roubin GS (1999) A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Invasive Cardiol 11(Suppl B):6B–13BPubMed

11.

Kahn ZM, Kumar M, Hollander G, Frankel R (2002) Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population. Catheter Cardiovasc Interv 55(1):8–13PubMed

12.

Hieb R, Neisen M, Hohenwalter E, Molnar J, Rilling W (2008) Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy. J Vasc Intervent Radiol 19(12):1704–1708CrossRef

13.

Jaff MR, Hadley G, Hermiller JB et al (2006) The safety and efficacy of the StarClose vascular closure system: the ultrasound substudy of the CLIP study. Catheter Cardiovasc Interv 68(5):684–689PubMed

14.

Hermiller JB, Simonton C, Hinohara T et al (2006) The StarClose vascular closure system: interventional results from the CLIP study. Catheter Cardiovasc Interv 68(5):677–683PubMed

15.

Branzan D, Sixt S, Rastan A et al (2009) Safety and efficacy of the StarClose vascular closure system using 7-F and 8-F sheath sizes: a consecutive single-center analysis. J Endovasc Ther 16(4):475–482PubMedCrossRef

16.

Desideri A, Tonello D, Coscarelli S, Alitto F, Daniotti A, Chioin R (2005) Early mobilization after percutaneous catheterization and vascular closure with a novel device (Star-Close). Am J Cardiol 96(10):1408–1409PubMedCrossRef

17.

Deuling JH, Vermeulen RP, Anthonio RA et al (2008) Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv 71(4):518–523PubMed

18.

Spiliopoulos S, Katsanos K, Karnabatidis D, Diamantopoulos A, Nikolaos C, Siablis D (2011) Safety and efficacy of the StarClose vascular closure device in more than 1,000 consecutive peripheral angioplasty procedures. J Endovasc Ther 18(3):435–443PubMedCrossRef

19.

Hermiller J, Simonton C, Hinohara T et al (2005) Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol 17(10):504–510PubMed

20.

Imam A, Carter RM, Phillips-Hughes J, Boardman P, Uberoi R (2007) StarClose vascular closure device: prospective study on 222 deployments in an interventional radiology practice. Cardiovasc Intervent Radiol 30(4):738–742PubMedCrossRef

21.

Ratnam LA, Raja J, Munneke GJ, Morgan RA, Belli A-M (2007) Prospective nonrandomized trial of manual compression and Angio-Seal and Starclose arterial closure devices in common femoral punctures. Cardiovasc Intervent Radiol 30(2):182–188PubMedCrossRef

22.

Ruygrok PN, Ormiston JA, Stewart JT et al (2005) Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition. Catheter Cardiovasc Interv 66(2):185–191PubMed

23.

Tay EL, Co M, Tai BC et al (2008) Clinical experience of StarClose vascular closure device in patients with first and recurrent femoral punctures. J Interv Cardiol 21(1):67–73PubMedCrossRef

24.

Gaba R, Parvinian A, Trinos E (2012) Safety and efficacy of StarClose SE vascular closure system in high-risk liver interventional oncology patients. J Vasc Access 13(4):415–420PubMed

25.

National Cancer Institute 2009 Common terminology criteria for adverse events (CTCAE) version 4, United States Department of Health and Human Services, Editor. Available: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed 22 Feb 2012

26.

Bashour FN, Teran JC, Mullen KD (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 95(10):2936–2939PubMedCrossRef

27.

Lechner K, Niessner H, Thaler E (1977) Coagulation abnormalities in liver disease. Semin Thromb Hemost 4(1):40–56PubMed

28.

Green G, Poller L, Thomson JM, Dymock IW (1976) Factor VII as a marker of hepatocellular synthetic function in liver disease. J Clin Pathol 29(11):971–975PubMedCentralPubMedCrossRef

29.

Patel T (1999) Surgery in the patient with liver disease. Mayo Clin Proc 74(6):593–599PubMedCrossRef

30.

Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29(6):1617–1623PubMedCrossRef

31.

Michalis LK, Rees MR, Patsouras D et al (2002) A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett). Cardiovasc Intervent Radiol 25(5):423–429PubMedCrossRef

32.

Ansel G, Yakubov S, Neilsen C et al (2006) Safety and efficacy of staple-mediated femoral arteriotomy closure: results from a randomized multicenter study. Catheter Cardiovasc Interv 67(4):546–553PubMed

33.

Nader RG, Garcia JC, Drushal K, Pesek T (2002) Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Invasive Cardiol 14(6):305–307PubMed

34.

Palmer BL, Gantt DS, Lawrence ME, Rajab MH, Dehmer GJ (2004) Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters. Am J Cardiol 93(1):96–97PubMedCrossRef

35.

Kim MC (2006) Vascular closure devices. Cardiol Clin 24(2):277–286 viiPubMedCrossRef

36.

Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M (2004) Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 291(3):350–357PubMedCrossRef

37.

Nikolsky E, Mehran R, Halkin A et al (2004) Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 44(6):1200–1209PubMed

38.

Dangas G, Mehran R, Kokolis S et al (2001) Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 38(3):638–641PubMedCrossRef

39.

Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM, Baddour LM (2005) Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 80(8):1011–1015PubMedCrossRef

40.

Wang DS, Chu LF, Olson SE et al (2008) Comparative evaluation of noninvasive compression adjuncts for hemostasis in percutaneous arterial, venous, and arteriovenous dialysis access procedures. J Vasc Interv Radiol 19(1):72–79PubMedCrossRef

41.

McTaggart RA, Raghavan D, Haas RA et al (2010) StarClose Vascular closure device: safety and efficacy of deployment and reaccess in a neurointerventional radiology service. Am J Neuroradiol 31:1148–1150PubMedCrossRef

42.

Gray BH, Miller R, Langan EM et al (2009) The utility of the StarClose arterial closure device in patients with peripheral arterial disease. Ann Vasc Surg 23:341–344PubMedCrossRef

43.

Li X, Wang Z, Chen J et al (2013) Safety and effectiveness of repeat arterial closure using the StarClose vascular closure device in patients with hepatic malignancy. Clin Radiol S0009–9260(13):00153

44.

Kirchhof C, Schickel S, Schmidt-Lucke C, Schmidt-Lucke JA (2002) Local vascular complications after use of the hemostatic puncture closure device Angio-Seal. Vasa 31(2):101–106PubMedCrossRef

45.

Wille J, Vos JA, Overtoom TT, Suttorp MJ, van de Pavoordt ED, de Vries JP (2006) Acute leg ischemia: the dark side of a percutaneous femoral artery closure device. Ann Vasc Surg 20(2):278–281PubMedCrossRef

46.

Durack JC, Thor Johnson D, Fidelman N, Kerlan RK, LaBerge JM (2012) Entrapment of the StarClose vascular closure system after attempted common femoral artery deployment. Cardiovasc Intervent Radiol 35(4):942–944PubMedCrossRef

47.

Gonsalves M, Walkden M, Belli AM (2008) Laceration of the common femoral artery following deployment of the Starclose vascular closure system. Cardiovasc Intervent Radiol 31(4):817–820PubMedCrossRef

48.

Castelli P, Caronno R, Piffaretti G, Tozzi M, Lomazzi C (2006) Incidence of vascular injuries after use of the Angio-Seal closure device following endovascular procedures in a single center. World J Surg 30(3):280–284PubMedCrossRef

49.

Mukhopadhyay K, Puckett MA, Roobottom CA (2005) Efficacy and complications of Angioseal in antegrade puncture. Eur J Radiol 56(3):409–412PubMedCrossRef

Titel: Safety and Efficacy of a Circumferential Clip-Based Vascular Closure Device in Cirrhotic and Coagulopathic Patients with Hepatocellular Carcinoma After Doxorubicin Drug-eluting Beads Transarterial Chemoembolization
verfasst von: Hasmukh J. Prajapati
Shoaib Rafi
Faramarz Edalat
David A. Kooby
Hyun S. Kim
Publikationsdatum: 01.06.2014
Verlag: Springer US
Erschienen in: CardioVascular and Interventional Radiology / Ausgabe 3/2014
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-013-0709-9

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Safety and Efficacy of a Circumferential Clip-Based Vascular Closure Device in Cirrhotic and Coagulopathic Patients with Hepatocellular Carcinoma After Doxorubicin Drug-eluting Beads Transarterial Chemoembolization

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Endovascular Treatment in Two Cases of Bilateral Ischemic Stroke

High On-Treatment Platelet Reactivity in Peripheral Endovascular Procedures

Fluoroscopically Guided Balloon Dilation for Benign Bronchial Stricture Occurring after Radiotherapy in Patients with Lung Cancer

Anomalous Unilateral Single Pulmonary Vein Mimicking Pulmonary Arteriovenous Malformation

Simultaneous Biliary Drainage and Portal Vein Embolization Before Extended Hepatectomy for Hilar Cholangiocarcinoma: Preliminary Experience

Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: Long-Term Results and Prognostic Factors in 168 Patients with Cirrhosis

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie